According to a new report published by Allied Market Research, titled, “Chronic Disease Management Market by Type (Solutions, Services), by Disease Type (Cardiovascular diseases, Diabetes, Cancer, Asthma, Chronic obstructive pulmonary disorders, Others), by End User (Healthcare Providers, Healthcare Payers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031″. According to the analyst of AMR, the global chronic disease management industry was pegged at $4.90 billion in 2021, and is expected to reach $14.88 billion by 2031, growing at a CAGR of 11.8% from 2022 to 2031.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/12692
Chronic Disease Management Market Overview:
Increase in geriatric population, surge in prevalence of chronic diseases including cancer and diabetes, and popularity of chronic disease management owing to integration of IT solutions have boosted the growth of the global chronic disease management market. However, dearth of skilled professionals and trained workforce hinder the market growth. On the contrary, rise in strategic initiatives such as mergers, acquisitions, and collaborations by major market players would open new opportunities in the future.
Chronic Disease Management Market Segmentation:
The solution segment dominated the market
By type, the solutions segment held the largest share in 2021, contributing to nearly two-thirds of the global chronic disease management market, and is expected to dominate the market. In addition, the segment is projected to manifest the highest CAGR of 12.0% during the forecast period, due to increase in awareness of the use of cloud-based and on-premise solutions in healthcare leads to the growth of the chronic disease management system. The report includes analysis of the services segment.
The healthcare providers segment held the largest share
By end user, the healthcare providers segment dominated the market in 2021, accounting for nearly half of the global chronic disease management market, due to prevalence of chronic diseases such as cancer, cardiovascular disease, heart disease, asthma, and chronic obstructive pulmonary disease increases. However, the others segment is expected to showcase the highest CAGR of 12.9% during the forecast period, owing to the increase in the prevalence of chronic diseases.
The diabetes segment to manifest the highest CAGR through 2031
By disease type, the diabetes segment is estimated to portray the highest CAGR of 12.7% during the forecast period. In addition, the segment held the largest share in 2021, accounting for more than one-fourth of the global chronic disease management market, and is expected to continue its dominance during the forecast period. This is due to increase in prevalence of diabetes because of changes in lifestyle, unhealthy diet, physical inactivity, and obesity. The report includes analysis of the cardiovascular diseases, cancer, asthma, chronic obstructive pulmonary disorders, others.
North America held the lion’s share
By region, the market across North America held the largest share in 2021, accounting for nearly half of the global chronic disease management market, and is expected to maintain the leading position throughout the forecast period. This is due to the prevalence of chronic diseases such as cancer, diabetes, cardiovascular disease, heart disease, and arthritis. However, the market across Asia-Pacific is expected to register the highest CAGR of 13.4% during the forecast period, owing to rise in the geriatric population in the region.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/12692
Chronic Disease Management Market: By Region Outlook
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Important Questions Being Answered by the Chronic Disease Management Market Report:
What is the Chronic Disease Management market size and growth?
What are the prominent and latest trends impacting the market?
Which is the largest regional market for Chronic Disease Management?
The report provides extensive competitive analysis and profiles of key market players, such as ZeOmega, Cedar Gate Technologies, Health Catalyst,Pegasystems Inc., Cognizant,Hinduja Global Solutions Ltd. (Bengaluru), Epic Systems Corporation, Casenet, LLC, NXGN Management, LLC, cliexa, Inc., ExlServings Holdings, Inc., Allscripts Healthcare, LLC, Vivify Health, Inc., Medecision,Infosys Limited, Koninklijke Philips N.V. (Netherlands), Altruista Health
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest.”
Top Trending Report:-
Companion Diagnostic Market Size, Share & Growth Outlook 2022-2030
Regenerative Medicine Market Size, Share & Growth Outlook 2022-2030
Wearable Patch Market Size, Share & Growth Outlook 2022-2030
Dental Implants and Prosthetics Market Size, Share & Growth Outlook 2022-2030
IVF Devices and Consumables Market Size, Share & Growth Outlook 2022-2030
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.